Skip to main content
. 2003 Jul 2;139(5):945–954. doi: 10.1038/sj.bjp.0705202

Table 2.

Pharmacokinetic parameters of norverapamil in control and IFN-induced inflamed rats (n=8/group)

Parameter Control INα2a
AUC0→8 (μg min−1 ml−1)    
S 62.0±12.4 108.9±15.7*
R 14.2±3.5 36.0±8.5*
Norverapamil : verapamil AUC ratio    
S 1.6±0.3 0.6±0.2*
R 2.5±0.9 1.3±0.4
λz (h−1)    
S 0.21±0.06 0.18±0.1
R 0.20±0.1 0.31±0.1
*

Different from control, P<0.05.

HHS Vulnerability Disclosure